Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 5Recruiting 3Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 85Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Leukemia 24Recurrence 16Lymphoma 14Myelodysplastic Syndromes 13Burkitt Lymphoma 13Congenital Abnormalities 12Lymphoma, Non-Hodgkin 10Leukemia, Monocytic, Acute 10Leukemia, Myelomonocytic, Acute 8Leukemia, Erythroblastic, Acute 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia, Megakaryoblastic, Acute 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Myeloproliferative Disorders 5Lymphoma, Large B-Cell, Diffuse 5Hodgkin Disease 5Multiple Myeloma 4Hematologic Neoplasms 4Blast Crisis 4Neoplasms 3Lymphoma, Mantle-Cell 3Lymphoma, B-Cell 3Leukemia, Myelomonocytic, Juvenile 3Leukemia, Biphenotypic, Acute 3Anemia, Refractory, with Excess of Blasts 3Thrombocytopenia 2Primary Myelofibrosis 2Neoplasms, Plasma Cell 2

Interventions

Cyclophosphamide 4Prednisone 3Lenalidomide 3fludarabine phosphate 2etoposide phosphate 2cobomarsen 2Whole-Body Irradiation 2Vorinostat 2Vincristine 2Stem Cell Transplantation 2Nivolumab 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Doxorubicin 2Bortezomib 2Alemtuzumab 2tazemetostat 1sargramostim 1romidepsin 1poly ICLC 1plerixafor 1pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1pegaspargase 1liposomal doxorubicin 1forodesine 1fludarabine 1duvelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Lymphoma, T-Cell × Cytarabine × Clear all
NCT00505921 2011-11-16

Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma

M.D. Anderson Cancer Center

Phase 2 Terminated
27 enrolled 5 charts
Lymphoid

Lymphoma, Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡